SRT 2104 5 mg | 99.83%
TargetMol
SRT 2104 (GSK2245840) is a selective and brain-permeable SIRT1 activator.
More Information Supplier PageSRT 2104
Search Results
Vatalanib dihydrochloride 100 mg | 100.00%
TargetMol
Vatalanib (PTK787) (IC50=37 nM) is an inhibitor of VEGFR2/KDR. It exhibits less effective against VEGFR1/Flt-1 and 18-fold against VEGFR3/Flt-4.
More Information Supplier PageVatalanib dihydrochloride
Vatalanib dihydrochloride 10 mg | 100.00%
TargetMol
Vatalanib (PTK787) (IC50=37 nM) is an inhibitor of VEGFR2/KDR. It exhibits less effective against VEGFR1/Flt-1 and 18-fold against VEGFR3/Flt-4.
More Information Supplier PageVatalanib dihydrochloride
Fatostatin hydrobromide 10 mg | Purity Not Available
TargetMol
Fatostatin hydrobromide (Fatostatin A HBr) ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
More Information Supplier PageFatostatin hydrobromide
Fatostatin hydrobromide 200 mg | Purity Not Available
TargetMol
Fatostatin hydrobromide (Fatostatin A HBr) ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
More Information Supplier PageFatostatin hydrobromide
Fatostatin hydrobromide 25 mg | Purity Not Available
TargetMol
Fatostatin hydrobromide (Fatostatin A HBr) ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
More Information Supplier PageFatostatin hydrobromide
Fatostatin hydrobromide 50 mg | Purity Not Available
TargetMol
Fatostatin hydrobromide (Fatostatin A HBr) ia an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
More Information Supplier PageFatostatin hydrobromide
Lercanidipine hydrochloride 10 mg | Purity Not Available
TargetMol
Lercanidipine hydrochloride is a calcium channel blocker of the dihydropyridine class.
More Information Supplier PageLercanidipine hydrochloride
Lercanidipine hydrochloride 200 mg | Purity Not Available
TargetMol
Lercanidipine hydrochloride is a calcium channel blocker of the dihydropyridine class.
More Information Supplier PageLercanidipine hydrochloride
Ospemifene 10 mg | 99.73%
TargetMol
Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013.
More Information Supplier PageOspemifene
